InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by Montalbano, John. Officer active across 2 companies, notably Eupraxia Pharmaceuticals Inc.. In total, 4 reports have been published. Split: 2 buys · 0 sell. Total volume traded: €93k. Activity tracked since 15 December 2025. The latest transaction was disclosed on 19 August 2026 (10 - Acquisition or disposition in the public market). Regulator: SEDI. The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
John Montalbano is a declarant, with 3 filings in total. The 3 sampled filings run from 2025-12-19 to 2026-07-02, and the modal transaction nature is 46 - Compensation for services. He is listed as 4 - Director of Issuer at Manulife Financial Corporation and Eupraxia Pharmaceuticals Inc., both on XTSE. The buy and sell amounts shown for the sampled filings are 0 and 0 EUR.